GL1X · GenesisL1 explorer

MolNFT v1 · #66956 · protein

Crystal structure of ERK2 bound to (S)-4-(2-(2-chlorophenylamino)-5- methylpyrimidin-4-yl)-N-(2-hydroxy-1-phenylethyl)-1H-pyrrole-2- carboxamide

3I60 · Mitogen-activated protein kinase 1: “Crystal structure of ERK2 bound to (S)-4-(2-(2-chlorophenylamino)-5…”. X-ray diffraction, 2 ligands (E86, SO4), 4 pockets (best druggability 0.65). MolNFT v1 #66956 on GenesisL1: 3D structure…

PDB
3I60
Type
protein
Length
335 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1
EC
2.7.11.24
UniProt
P28482
Ligands
E86, SO4
Pockets
4 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 1 (EC 2.7.11.24)protein33541% helix, 16% strandP28482

Ligands and binding sites

  • E86 · 4-{2-[(2-chlorophenyl)amino]-5-methylpyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-phenylethyl]-1H-pyrrole-2-carboxamide · ligand · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13310.650.8134E86
2630.360.7816empty
3520.290.7514empty
4570.280.7414empty

Compared structures

  • 3I60 · Crystal structure of ERK2 bound to (S)-4-(2-(2-chlorophenylamino)-5-methylpyrimidin-4-yl)… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.